PIK3CA and colitis: Another PI3-K inhibitor PIK-75 which inhibits both the α and γ isoforms has also been shown to attenuate DSS-induced colitis by suppressing the production of pro-inflammatory mediators in an NFκB-dependent manner as well as reducing the inflammatory cellular infiltrate into the colonic interstitium [78].